ArticleFrontiers in physiology2024
SRPNet: stroke risk prediction based on two-level feature selection and deep fusion network.
Article in Frontiers in physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Stroke is one of the major chronic non-communicable diseases (NCDs) with high morbidity, disability and mortality. The key to preventing stroke lies in controlling risk factors. However, screening risk factors and quantifying stroke risk levels remain challenging. Methods: A novel prediction model for stroke risk based on two-level feature selection and deep fusion network (SRPNet) is proposed to solve the problem mentioned above. First, the two-level feature selection method is used to screen comprehensive features related to stroke risk, enabling accurate identification of significant risk factors while eliminating redundant information. Next, the deep fusion network integrating Transformer and fully connected neural network (FCN) is utilized to establish the risk prediction model SRPNet for stroke patients. Results: We evaluate the performance of the SRPNet using screening data from the China Stroke Data Center (CSDC), and further validate its effectiveness with census data on stroke collected in affiliated hospital of Jining Medical University. The experimental results demonstrate that the SRPNet model selects features closely related to stroke and achieves superior risk prediction performance over benchmark methods. Conclusions: SRPNet can rapidly identify high-quality stroke risk factors, improve the accuracy of stroke prediction, and provide a powerful tool for clinical diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.